Roos Bleckman

Roos Bleckman is a Researcher at the University of Groningen, specializing in gastrointestinal stromal tumors (GIST) and soft tissue sarcomas. Their work focuses on DNA methylation, mutation profiles, and clinical pharmacokinetics, with collaborations in surgical oncology and therapeutic drug monitoring.

Research Interests: Roos Bleckman’s research spans Gastrointestinal Stromal Tumor, Soft Tissue Sarcoma, and Therapeutic Drug Monitoring. Recent projects include exploring genomic alterations in GIST, neoadjuvant therapy outcomes, and clinical feasibility of anti-cancer drugs.

Article Trends: Their publications emphasize minimally invasive surgery for GIST, DNA methylation in sarcomas, and pharmacological monitoring of drugs like pazopanib and imatinib. These works align with translational medicine and precision oncology.

Media Contributions: Roos Bleckman has provided expert commentary on sustainable practices in healthcare, specifically reducing operating theater waste at the University Medical Center Groningen (UMCG).